|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.11 EUR | +1.35% |
|
+1.53% | -0.74% |
MarketScreener Strategies
Search
| Sanofi: Treatment for re-rating isn’t easy | April 07, 2026 at 01:16 pm | |
| Sanofi prepares for the future and once again raises its sacrosanct dividend | January 30, 2026 at 12:04 pm | |
| Sanofi: More than operational delivery, markets seek pipeline answers | January 29, 2026 at 04:11 pm | |
| Sanofi reduces valuation after R&D setbacks | December 31, 2025 at 06:03 am | |
| Trump wants to reduce drug prices by up to 80% | May 12, 2025 at 09:45 am | |
| On the stockmarket, the pharmaceutical industry is wary of FDA's new strongman | May 07, 2025 at 11:30 am | |
![]() | Sanofi and Novartis are calling for American drug prices in Europe | April 23, 2025 at 08:26 am |
| Sanofi : The Doliprane case | October 18, 2024 at 02:16 pm | |
![]() | Sanofi : reportedly receives two bids of 15 billion for its consumer healthcare unit | September 25, 2024 at 10:36 am |
| Sanofi : In the hot seat | October 30, 2023 at 10:52 am | |
| Sanofi : The road to reinvention | January 10, 2022 at 11:19 am | |
| Sanofi : At a crossroads | August 07, 2018 at 04:56 pm |
No results for this search
Filters
Headlines
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition


















